<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694486/" ref="ordinalpos=1611&amp;ncbi_uid=5079528&amp;link_uid=PMC3694486" image-link="/pmc/articles/PMC3694486/figure/fig5/" class="imagepopup">Figure 5.  From: Puerarin Suppress Apoptosis of Human Osteoblasts via ERK <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">ERK signaling pathway and estrogen receptor mediated the antiapoptotic effects of puerarin in hOBs. Cells were incubated with PD98059 (10 μM) and/or ICI 182780 (10 μM) for 3 h prior to treatment with 10−8 M puerarin for 48 h. The bars represented the mean ± SD (n = 6). *P &lt; 0.05, as compared with the puerarin-treated cells; **P &lt; 0.05, as compared with the serum-free treated cells.</div></div>